Paradigm Capital Management Inc’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
BH
AC
VCM
RA
WCM
BAM
Paradigm Capital Management Inc's ANGO Position: Q1 2026 in Review
Paradigm Capital Management Inc increased its AngioDynamics (ANGO) stake by 5.9% in Q1 2026, buying an estimated $433K and bringing the position to 718,200 shares worth $8.17M. The position accounts for 0.31% of the portfolio, ranked #47.
Paradigm Capital Management Inc first reported a position in ANGO in Q2 2014 and has held it in 21 quarters since. The position peaked at $9.09M in Q2 2014. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.
- Paradigm Capital Management Inc held 718,200 shares of AngioDynamics worth $8.17M as of Q1 2026.
- Paradigm Capital Management Inc bought 40,000 AngioDynamics shares in Q1 2026, an estimated $433K.
- AngioDynamics made up 0.31% of Paradigm Capital Management Inc's portfolio in Q1 2026, its #47 holding.
- Paradigm Capital Management Inc first reported a position in AngioDynamics in Q2 2014 and has held it in 21 quarters since.
- Paradigm Capital Management Inc's AngioDynamics position peaked at $9.09M in Q2 2014.
- 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.
Based on Paradigm Capital Management Inc's 13F filing for Q1 2026, filed 14 May 2026.